Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Evan A Stein, MD PhD
LIB Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vmmc & Safdarjung Hospital
Delhi, National Capital Territory of Delhi, India
- Cims Hospital Pvt. Ltd
Ahmedabad, India
- G.B. Pant Institute of Postgraduate Medical Education & Research
New Delhi, India
- Department of Medicine, Hadassah University Hospital
Jerusalem, Israel
- Rabin Medical Center, Beilinson Hospital,
Petah Tikva, Israel
- Lipid Clinic, Oslo University Hospital
Oslo, Norway
- Carbohydrate and Lipid Metabolism Research Unit
Johannesburg, Gauteng, South Africa
- Division of Lipidology, Department of Medicine University of Cape Town
Cape Town, Western Province, South Africa
- Ege University Medical School
Izmir, Bornova, Turkey (Türkiye)
- Afyonkarahisar Health Sciences University
Afyonkarahisar, Turkey (Türkiye)
- Northshore University Health System
Evanston, Illinois, United States
- Metabolic & Atherosclerosis Research Center (marc)
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Dec 2019
- Primary completion
- 12 Sept 2022
- Completion
- 30 Jan 2023
- Last update posted
- 29 Mar 2023
- Registered enrollment
- 65
- Registry id
- NCT04034485
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.